Antiplatelet Therapy in Patients With Abdominal Aortic Aneurysm Without Symptomatic Atherosclerotic Disease

IMPORTANCE: Patients with abdominal aortic aneurysm have a high risk of ischemic events associated with concomitant atherosclerotic cardiovascular disease, and current clinical practice guidelines recommend antiplatelet therapy to mitigate this risk. However, in patients with aneurysms without sympt...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolajsen, Chalotte W., Søgaard, Mette, Jensen, Martin, Eldrup, Nikolaj, Larsen, Torben B., Goldhaber, Samuel Z., Behrendt, Christian-Alexander, Nielsen, Peter B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600585/
https://www.ncbi.nlm.nih.gov/pubmed/37878310
http://dx.doi.org/10.1001/jamanetworkopen.2023.39715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600585/
https://www.ncbi.nlm.nih.gov/pubmed/37878310
http://dx.doi.org/10.1001/jamanetworkopen.2023.39715

Ejemplares similares